Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 3/2017

Ausgabe 3/2017

Inhaltsverzeichnis ( 15 Artikel )

07.09.2017 | editorial | Ausgabe 3/2017

Development of chemotherapeutics in oncology: is there anything new?

Holger Rumpold, Thomas Winder

12.09.2017 | editorial | Ausgabe 3/2017

An Austrian view of the 2017 consensus for the treatment of early breast cancer

Guenther G. Steger MD

12.09.2017 | short review | Ausgabe 3/2017

What’s new in chemotherapy for non-small cell lung cancer?

Christian Britschgi MD, PhD

22.08.2017 | short review | Ausgabe 3/2017

New chemotherapies in breast cancer

Matthias Ranftler MD, Kathrin Strasser-Weippl MD, MBA

07.09.2017 | short review | Ausgabe 3/2017

New chemotherapies in gastric adenocarcinoma

Ewald Wöll MD

07.09.2017 | short review | Ausgabe 3/2017 Open Access

Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer

Markus Kieler M.D., Matthias Unseld M.D., Ph.D., Daniela Bianconi M.Sc., Ph.D., Gerald W. Prager M.D.

01.09.2017 | short review | Ausgabe 3/2017

Chemotherapies and future directions in metastatic colorectal cancer

PD Dr. Thomas Winder PhD

01.09.2017 | short review | Ausgabe 3/2017

Novel therapeutics in supportive cancer treatment

Dr. Clemens Dormann

21.08.2017 | review | Ausgabe 3/2017

Renal insufficiency in patients with multiple myeloma

Dr. Boris Bozic, Dr. Sophie Hölbling, Dr. Vanessa Völkel, Prim. Prof. Dr. Christian Sebesta

18.07.2017 | case report | Ausgabe 3/2017

Activity of panobinostat in combination with bortezomib and dexamethasone in advanced, proteasome inhibitor refractory multiple myeloma

Branka Petricevic, Wolfgang Hilbe, Niklas Zojer

29.03.2017 | review | Ausgabe 3/2017

Prognostic significance of aberrant expression of CD markers in acute lymphoblastic leukemia

Maria Kavianpour, Neda Ketabchi, Najmaldin Saki

27.03.2017 | case report | Ausgabe 3/2017

Disease control with brentuximab vedotin in an aged patient with primary cutaneous anaplastic large-cell lymphoma

Sonja Burgstaller MD, Josef Thaler

21.08.2017 | comment | Ausgabe 3/2017

Highlights from the 2017 St. Gallen Breast Cancer Consensus

Prof. Dr. Georg Pfeiler MD, Prof. Dr. Rupert Bartsch, Univ. Prof. Dr. Florian Fitzal MBA F.E.B.S.

28.06.2017 | short review | Ausgabe 3/2017 Open Access

New diagnostic tools for breast cancer

Pascal A. T. Baltzer M.D., Panagiotis Kapetas, Maria Adele Marino M.D., Paola Clauser M.D.

07.06.2017 | short review | Ausgabe 3/2017 Open Access

Local therapies for breast cancer

PD Dr. Ruth Exner F.E.B.S.

Aktuelle Ausgaben